NuPathe plans Zelrix migraine patch refiling in US for first half of 2012
16 November 2011
Donna Young
Please Login to read the full article.
16 November 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- As NuPathe hopes for 2012 Zelrix migraine patch launch, sells $30M in stock to investor
- UCB gains double US win for Neupro in Parkinson's, RLS
- Pozen migraine drug licensed to Desitin for commercialisation in Europe
- Investors hopeful for lorcaserin, but analysts fret over CV, ‘modest’ weight loss
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
